FDA Authorizes First At-Home Sample Collection Test for COVID-19

April 21, 2020 by Dan McCue
FDA Authorizes First At-Home Sample Collection Test for COVID-19
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2. (NIAID-RML via AP)

WASHINGTON – The Food and Drug Administration Tuesday approved the first diagnostic test for the coronavirus that allows people to collect their sample at home — a development that could greatly expand testing options in states fighting to corral the outbreak.

The COVID-19 RT-PCR from LabCorp will initially only be available to health care workers and first responders under a doctor’s orders.

The sample, collected via swab, will still have to be shipped for processing back to LabCorp, which operates diagnostic labs throughout the U.S.

Before gaining access to the home test, people are screened using an online questionnaire.

If authorized by a physician, LabCorp will ship a testing kit to their home.

The kit includes cotton swabs, a collection tube, an insulated pouch and box to ship the specimen back to LabCorp. To take a sample, a cotton swab is swirled in each nostril. The test results are posted online to a secure company website.

The company said it will make the test kit available in the coming weeks. Each will cost $119. The kits will not be available in Maryland, New Jersey, New York and Rhode Island. Those states have laws prohibiting testing with at-home kits.

FDA Commissioner Stephan Hawn said in a statement the agency authorized the self-swab test based on data showing it is “as safe and accurate as sample collection at a doctor’s office, hospital or other testing site.”

“Throughout this pandemic we have been facilitating test development to ensure patients access to accurate diagnostics, which includes supporting the development of reliable and accurate at-home sample collection options,” he said.

“The FDA’s around-the-clock work since this outbreak began has resulted in the authorization of more than 50 diagnostic tests and engagement with over 350 test developers,” he continued.

The FDA said it will continue to work with test developers to determine whether or not Q-tip-style cotton swabs can be used safely and effectively with other tests.

A+
a-
  • Coronavirus
  • FDA
  • Food and Drug Administration
  • home testing kit
  • In The News

    Health

    Voting

    Health

    April 23, 2024
    by Dan McCue
    President Lays Out New Steps for Protecting Nation’s Waters

    WASHINGTON — The Biden administration on Tuesday set out a new national goal for conserving and restoring the United States’... Read More

    WASHINGTON — The Biden administration on Tuesday set out a new national goal for conserving and restoring the United States’ freshwater resources, including 8 million acres of wetlands and 100,000 miles of rivers and streams. Officials unveiled the plan as state, tribal and local leaders from... Read More

    April 23, 2024
    by Beth McCue
    Study Finds Next-Gen Antibiotics Underutilized

    WASHINGTON — A new study conducted by researchers at the National Institutes of Health found clinicians frequently continue to treat... Read More

    WASHINGTON — A new study conducted by researchers at the National Institutes of Health found clinicians frequently continue to treat antibiotic-resistant infections with older generic antibiotics considered to be less effective and less safe than newer ones. Researchers examined the factors influencing doctors’ preference for older... Read More

    Idaho Group Says It Is Exploring a Ballot Initiative for Abortion Rights and Reproductive Care

    BOISE, Idaho (AP) — A new Idaho organization says it will ask voters to restore abortion access and other reproductive health care... Read More

    BOISE, Idaho (AP) — A new Idaho organization says it will ask voters to restore abortion access and other reproductive health care rights in the state after lawmakers let a second legislative session end without modifying strict abortion bans that have been blamed for a recent exodus of health... Read More

    Seattle Hospital Won't Turn Over Gender-Affirming Care Records in Lawsuit Settlement With Texas

    DALLAS (AP) — Texas Attorney General Ken Paxton is dropping a request for a Seattle hospital to hand over records regarding gender-affirming treatment potentially... Read More

    DALLAS (AP) — Texas Attorney General Ken Paxton is dropping a request for a Seattle hospital to hand over records regarding gender-affirming treatment potentially given to children from Texas as part of a lawsuit settlement announced Monday. Seattle Children's Hospital filed the lawsuit against Paxton's office in December in response to the... Read More

    April 22, 2024
    by Dan McCue
    New Rules Bolster Reproductive Health Care Privacy Under HIPAA

    WASHINGTON — The Biden administration is bolstering existing HIPAA health care privacy rules to provide added protection to women lawfully... Read More

    WASHINGTON — The Biden administration is bolstering existing HIPAA health care privacy rules to provide added protection to women lawfully exercising their right to terminate a pregnancy. The rules will also extend to a woman’s family members and doctors. The Department of Health and Human Services... Read More

    April 22, 2024
    by Dan McCue
    Moderna Suspends Construction on Kenyan Manufacturing Facility

    CAMBRIDGE, Mass. — Moderna said it has paused efforts to build an mRNA manufacturing facility in Kenya due to uncertainty... Read More

    CAMBRIDGE, Mass. — Moderna said it has paused efforts to build an mRNA manufacturing facility in Kenya due to uncertainty over the future demand for COVID-19 vaccines in Africa. According to a statement posted on the drugmaker’s website last week, demand for the vaccines has declined... Read More

    News From The Well
    scroll top